Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Generalisation from phase III clinical trials: survival, quality of life, and health economics | 1997 | |||
Analysis of the cost-effectiveness of paclitaxel as alternative combination therapy for advanced ovarian cancer | 1997 | |||
The Effect of Pharmacoeconomics on Company Research and Development Decisions | PharmacoEconomics |
| 29 | 1997 |
An incentive approach to physician implementation of medical practice guidelines | Health Economics |
| 1997 | |
Reducing patient eligibility criteria in cancer clinical trials | 1996 |